Market Research Logo

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark

Summary

GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Denmark. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Denmark is one of the largest healthcare markets, with a strong focus on pharma R&D. It spends approximately 10.4% of its GDP on healthcare. The pharmaceutical market declined from $3.87 billion in 2009 to $3.16 billion in 2016, at a negative CAGR of 2.7%. It is expected to decrease at a negative CAGR of 2.8% from $3.07 billion in 2017 to $2.74 billion in 2021. The Danish medical device market was valued at $1.40 billion in 2009, which increased to $1.81 billion in 2016. The main segments were in vitro diagnostics, ophthalmic devices, cardiovascular devices, orthopedic devices and healthcare IT. The increasing elderly population and associated disease burden are expected to drive the growth of the pharmaceutical market. However, the government initiated price-cap agreements act as a major barrier for the pharmaceutical market.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Denmark, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Lundbeck, Ferring Pharmaceuticals, Leo Pharma, Novo Nordisk and Orifarm) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, GE Healthcare, Roche Diagnostics, Essilor and Zimmer Biomet)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Denmark
  • Porter’s five forces analysis for pharmaceutical and medical devices market of Denmark
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Danish healthcare market.
Reasons to buy

This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving the Danish healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in the Danish healthcare market.


Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porter’s Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix
List of Tables
Table 1: Pharmaceutical Market, Denmark, Sales of Patented Drug Products by Major Therapeutic Class ($m), 2016 21
Table 2: Pipeline, Lundbeck, Denmark 24
Table 3: Pipeline, NovoNordisk, Denmark 27
Table 4: Pipeline, Leo Pharma, Denmark 30
Table 5: Pipeline, Ferring Pharmaceuticals, Denmark 36
Table 6: Medical Device Market, Denmark, Revenue by Segment 41
Table 7: IVD Devices Market, Denmark, Revenue and Market Share of Major Players 42
Table 8: Ophthalmic Devices Market, Denmark, Revenue and Market Share of Major Players 43
Table 9: Cardiovascular Devices Market, Denmark, Revenue and Market Share of Major Players 44
Table 10: Orthopedic Devices Market, Denmark, Revenue and Market Share of Major Players 45
Table 11: Healthcare IT Market, Denmark, Revenue and Market Share of Major Players 46
Table 12: Sygeforsikringen Danmark Plans, 2017 80
Table 13: Net Assessment and Clock Stop Times, 2015, Denmark 85
Table 14: Market Authorization Fees, 2017, Denmark 85
Table 15: Patent Fees, 2017, Denmark 95
Table 16: Trademark Fees, 2017, Denmark 98
Table 17: Advertising Regulation, 2017, Denmark 100
Table 18: Advertising of pharmaceutical products through other mass media, 2017, Denmark 100
Table 19: Label of a pharmaceutical product, Denmark, 2017 101
Table 20: Labeling of Small Packages 101
Table 21: Label of Radiopharmaceutical product 101
Table 22: Labeling and Packaging leaflet 102
List of Figures
Figure 1: Pharmaceutical Market, Denmark, Revenue ($bn), 2009-2016 8
Figure 2: Medical Device Market, Denmark, Revenue ($bn), 2009-2016 8
Figure 3: Number of Deals (2016-2017) 12
Figure 4: 2016-17 Deal Overview By Region 12
Figure 5: Country Profile, Denmark, 2017 14
Figure 6: Pharmaceutical Market, Denmark, Revenue ($bn), 2009-2016 16
Figure 7: Pharmaceutical Market, Denmark, Revenue Forecast ($bn), 2017-2021 16
Figure 8: Pharmaceutical Market, Denmark, Pharmaceutical Exports 17
Figure 9: Pharmaceutical Market, Denmark, Top Export Partners 17
Figure 10: Pharmaceutical Market, Denmark, Pharmaceutical Imports 18
Figure 11: Pharmaceutical Market, Denmark, Top Import Partners 18
Figure 12: Pharmaceutical Market, Denmark, Supply Channels 19
Figure 13: Pharmaceutical Market, Denmark, Sales of Patented Drug Products by Major Therapeutic Class ($m), 2015 21
Figure 14: Pharmaceutical Market, Denmark, Major Players 23
Figure 15: Medical Device Market, Denmark, Revenue 40
Figure 16: Medical Device Market, Denmark, Revenue Forecast 40
Figure 17: Medical Device Market, Denmark, Revenue by Segment 41
Figure 18: In vitro Diagnostics Market, Denmark, Revenue 42
Figure 19: In vitro Diagnostics Market, Denmark, Market Share of Major Players 42
Figure 20: Ophthalmic Devices Market, Denmark, Revenue 43
Figure 21: Ophthalmic Devices Market, Denmark, Market Share of Major Players 43
Figure 22: Cardiovascular Devices Market, Denmark, Revenue 44
Figure 23: Cardiovascular Devices Market, Denmark, Market Share of Major Players 44
Figure 24: Orthopedic Devices Market, Denmark, Revenue 45
Figure 25: Orthopedic Devices Market, Denmark, Market Share of Major Players 45
Figure 26: Healthcare IT Market, Denmark, Revenue 46
Figure 27: Healthcare IT Market, Denmark, Market Share of Major Players 46
Figure 28: Diagnostic Market, Denmark, Revenue, 2009-2016 47
Figure 29: Diagnostic Market, Denmark, Revenue Forecast, 2017-2021 47
Figure 30: Medical Device Market, Denmark, Revenue of Major Players 49
Figure 31: Deal Value and Deal Count, Pharmaceutical Market, Denmark, 2016-2017 69
Figure 32: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Denmark, 2016-2017 69
Figure 33:Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Denmark, 2016-2017 69
Figure 34: Top 5 therapy area by deal value, Pharmaceutical Market, Denmark, 2016-2017 70
Figure 35: Top 5 therapy area by deal number, Pharmaceutical Market, Denmark, 2016-2017 70
Figure 36: M&A deals by therapy area, Pharmaceutical Market, Denmark, 2016-2017 (by value and by number) 70
Figure 37: Venture Financing deals by therapy area, Pharmaceutical Market, Denmark, 2016-2017 (by value and by number) 70
Figure 38: Private Equity Deals by Therapy Area, Pharmaceutical Market Denmark, 2016-2017 (by value and by number) 70
Figure 39: Deal Analysis, Medical Device Market Deals, Denmark, 2016 - 2017 (by deal value, $m) 71
Figure 40: Deal Analysis, Medical Device Market Deals, Denmark, 2016 - 2017 (By deal Count) 71
Figure 41: Deal Analysis, Medical Device Market deals share (by deal count), Denmark, 2016 - 2017 71
Figure 42: Deal Analysis, Medical Device Market deals share (by deal value), Denmark, 2016 - 2017 71
Figure 43: Deal Analysis, Top Five Therapy Area by Deal Value, Medical Device, Denmark, 2016-2017 72
Figure 44: Deal Analysis, Top Five Therapy Area by Deal Number, Medical Device, Denmark, 2016-2017 72
Figure 45: Deal Analysis, M&A deals by therapy area, Medical Device, Denmark, 2016-2017 (by value and by number) 72
Figure 46: Deal Analysis, Venture Financing deals by therapy area, Medical Device, Denmark, 2016-2017 (By value and by number) 72
Figure 47: Deal Analysis, Private Equity deals by therapy area, Medical Device, Denmark, 2016-2017 (By value and by number) 72
Figure 48: Healthcare System, Denmark 77
Figure 49: Reimbursement Process, Denmark 78
Figure 50: Financial Flow, Denmark 79
Figure 51: Out-of-Pocket Expenditure (% of total expenditure on health) 81
Figure 52: Pharmaceutical and Consumer Price Index 81
Figure 53: Medical Products Agency, Organization Chart, Denmark 83
Figure 54: New Drug Approval Process, National Procedure, Denmark 84
Figure 55: Centralized Procedure, 2017, Denmark 86
Figure 56: Decentralized Procedure, 2017, Denmark 87
Figure 57: Mutual Recognition Procedure, 2017, Denmark 88
Figure 58: Conformity Assessment of Class I Medical Devices, EU, 2017 90
Figure 59: Conformity Assessment of Class IIa Medical Devices, EU, 2017 91
Figure 60: Conformity Assessment of Class IIb Medical Devices, EU, 2017 92
Figure 61: Conformity Assessment of Class III Medical Devices, EU, 2017 93
Figure 62: European Patent Approval Process, EU, 2017 96
Figure 63: Unitary Patent Approval Process, EU, 2017 97
Figure 64: Clinical Trial Approval Process, Denmark, 2017 99
Figure 65: Number of Hospitals, Denmark, 2009-2016 105
Figure 66: Diagnostic Equipment (per 100,000 population), Denmark, 2009- 2015 105
Figure 67: Hospital Beds (per 1,000 population), Denmark 106
Figure 68: Acute Care Hospital Beds (per 1,000 population), Denmark 106
Figure 69: Psychiatric Hospital Beds (per 1,000 population), Denmark 106
Figure 70: Life Expectancy, 2009-2015, Denmark 107
Figure 71: Immunization Rate (%), 2009-2016, Denmark 107
Figure 72: PM2.5 (μg per m3), Denmark, 2009-2015 108
Figure 73: CO2 Emissions (million tons), Denmark, 2009-2015 108
Figure 74: Physicians (per 1,000 population), Denmark, 2009-2015 109
Figure 75: Nurses (per 1,000 population), Denmark, 2009-2015 109
Figure 76: Dentists (per 1,000 population), Denmark, 2009-2015 109
Figure 77: Pharmacists (per 1,000 population), Denmark, 2009-2015 109
Figure 78: Major Causes of Mortality (per 100,000 population), Denmark, 2015 110
Figure 79: Major Causes of Male Mortality, Denmark, 2015 110
Figure 80: Major Causes of Female Mortality, Denmark, 2015 110
Figure 81: Disability-Adjusted Life Years by Major Disease (‘000), Denmark, 2015 110
Figure 82: Healthcare Expenditure as Percentage of GDP (%), Denmark, 2009-2016 111
Figure 83: Public-Private Share (%), Denmark, 2009-2015 111
Figure 84: Major Components of Healthcare Spending (%), Denmark, 2016 112
Figure 85: Opportunities and Challenges, Denmark 116

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report